Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 167,164,496
  • Shares Outstanding, K 5,666,593
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.69
  • Price/Sales 2.87
  • Price/Cash Flow 10.07
  • Price/Book 1.83
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 28.50% ( +1.41%)
  • Historical Volatility 19.38%
  • IV Percentile 76%
  • IV Rank 66.40%
  • IV High 33.73% on 10/27/23
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.29
  • Today's Volume 112,403
  • Volume Avg (30-Day) 129,989
  • Put/Call OI Ratio 1.07
  • Today's Open Interest 2,769,294
  • Open Int (30-Day) 2,811,367

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.46
  • Number of Estimates 8
  • High Estimate 0.54
  • Low Estimate 0.34
  • Prior Year 0.67
  • Growth Rate Est. (year over year) -31.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.07 +10.42%
on 06/27/24
30.69 -2.61%
on 07/18/24
+1.53 (+5.39%)
since 06/24/24
3-Month
25.20 +18.61%
on 04/26/24
30.69 -2.61%
on 07/18/24
+3.62 (+13.78%)
since 04/24/24
52-Week
25.20 +18.61%
on 04/26/24
37.72 -20.76%
on 07/25/23
-7.62 (-20.31%)
since 07/24/23

Most Recent Stories

More News
Alphabet and Tesla Lead Tech Rout: Investors Reassess AI Frenzy

Wall Street faced a significant setback as the megacap earnings season got off to a disappointing start, raising concerns that the artificial intelligence (AI) frenzy fueling the bull market may be overblown....

TSLA : 215.99 (-12.33%)
TXN : 198.28 (-0.01%)
T : 19.16 (+5.22%)
V : 254.17 (-4.01%)
PFE : 29.98 (+1.63%)
BXMT : 17.35 (-11.61%)
CRWD : 258.14 (-3.99%)
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer

With danuglipron, Pfizer could become a major player in the massive GLP-1 agonist market.

PFE : 29.98 (+1.63%)
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche

Neither is a leader right now, but one of them might be on track to change that.

LLY : 859.88 (-2.10%)
PFE : 29.98 (+1.63%)
RHHBY : 38.5400 (+0.89%)
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.

MRK : 125.92 (+1.24%)
LLY : 859.88 (-2.10%)
PFE : 29.98 (+1.63%)
OPHLY : 4.7900 (+0.63%)
ABCL : 3.01 (-2.90%)
FATE : 5.18 (-7.00%)
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.

The pharma's latest push to develop a weight loss pill isn't going well.

LLY : 859.88 (-2.10%)
PFE : 29.98 (+1.63%)
Premarin® / Premplus® Class Action Settlement Approved

/CNW/ -- Merchant Law Group LLP and Pfizer Inc., Pfizer Canada Inc., Pfizer Canada Inc.'s successor Pfizer Canada ULC, Wyeth, Wyeth Canada, Wyeth Canada Inc.,...

PFE : 29.98 (+1.63%)
Time to Pounce: 2 Beaten-Down Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought Right Now

Despite their recent underperformance, these two phenomenal dividend stocks -- sporting an average yield of 5.79% -- have the recipes to make their patient shareholders notably richer.

T : 19.16 (+5.22%)
PFE : 29.98 (+1.63%)
Forget Medical Properties Trust: This High-Yielding Dividend Stock Is a Much Better Buy

Medical Properties Trust's yield looks appealing, but it wouldn't have made up for the stock's 70% decline over the last three years.

MPW : 5.12 (+3.02%)
PFE : 29.98 (+1.63%)
Here's What to Expect From Pfizer’s Next Earnings Report

As Pfizer gears up to release its second-quarter earnings this month, analysts project a double-digit bottom-line dip.

PFE : 29.98 (+1.63%)
$SPX : 5,427.13 (-2.31%)
XLV : 149.87 (+0.83%)
1 Big Pharma Dividend Stock to Snag While It's Still Cheap

Pfizer's stock presents a compelling investment opportunity, trading at an attractive valuation with a high dividend yield, as the company makes promising progress on its oral obesity drug, danuglipron,...

PFE : 29.98 (+1.63%)
NVO : 131.60 (-1.26%)
LLY : 859.88 (-2.10%)
BLK : 827.65 (-2.02%)
STT : 82.96 (-1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 29.96
2nd Resistance Point 29.80
1st Resistance Point 29.65
Last Price 29.98
1st Support Level 29.34
2nd Support Level 29.18
3rd Support Level 29.03

See More

52-Week High 37.72
Fibonacci 61.8% 32.94
Fibonacci 50% 31.46
Fibonacci 38.2% 29.98
Last Price 29.98
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar